# Orphenadrine Citrate

NDC: 60760-810
Generic name: Orphenadrine Citrate
Labeler / Manufacturer: St. Mary's Medical Park Pharmacy
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, EXTENDED RELEASE
Routes: ORAL
Marketing started: 19980619

FDA application: ANDA040284

## Active ingredients

- ORPHENADRINE CITRATE: 100 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"60760-810"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=60760-810
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=59000b66-166e-75d2-e053-2a91aa0af3c0